These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11206672)

  • 21. Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study.
    Carr AA; Bottini PB; Prisant LM; Fisher LD; Devane JG; O'Brien DE; Rhoades RB
    J Clin Pharmacol; 1991 Feb; 31(2):144-50. PubMed ID: 2010560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
    Glasser SP; Neutel JM; Gana TJ; Albert KS
    Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single daily dose of verapamil (COER-24 180/24 mg) in mild and moderate hypertension evaluated by ambulatory blood pressure monitoring].
    Ortega KC; Santello JL; Nobre F; Kohlman Júnior O; Jardim PC; da Costa LS; Rosito GA; Raposo Filho JJ; Oigman W; Mion Júnior D
    Arq Bras Cardiol; 2000 Mar; 74(3):283-90. PubMed ID: 10951830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.
    White WB; Mehrotra DV; Black HR; Fakouhi TD
    Am J Cardiol; 1997 Aug; 80(4):469-74. PubMed ID: 9285660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.
    Neutel JM; Smith DH; Lefkowitz MP; Cargo P; Alemayehu D; Weber MA
    J Hum Hypertens; 1995 Sep; 9(9):723-7. PubMed ID: 8551485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension. The Verapamil-SR Study Group.
    McMahon FG; Reder RF
    J Clin Pharmacol; 1989 Nov; 29(11):1003-7. PubMed ID: 2689469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group.
    White WB; Anders RJ; MacIntyre JM; Black HR; Sica DA
    Am J Cardiol; 1995 Aug; 76(5):375-80. PubMed ID: 7639163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Antonicelli R; Omboni S; Giovanni DC; Ansuini R; Mori A; Gesuita R; Parati G; Paciaroni E
    Drugs Aging; 2002; 19(7):541-51. PubMed ID: 12182690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chronotherapeutic approach to the management of hypertension.
    White WB
    Am J Hypertens; 1996 Apr; 9(4 Pt 3):29S-33S. PubMed ID: 8722414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease.
    Smolensky MH; Portaluppi F
    Am Heart J; 1999 Apr; 137(4 Pt 2):S14-S24. PubMed ID: 10097242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.